163705-86-0

Basic information

• Product Name: Cyclohexanecarboxylic acid, 2-[[(1R)-1-phenylethyl]amino]-, ethyl ester, (1S,2R)-
• CAS NO: 163705-86-0
• Molecular Formula: C17H25NO2
• Molecular Weight: 275.391
• Mol File: 163705-86-0.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 369.7±35.0 °C(Predicted)
• Density: 1.04±0.1 g/cm3(Predicted)
• CAS DataBase Reference: Cyclohexanecarboxylic acid, 2-[[(1R)-1-phenylethyl]amino]-, ethyl ester, (1S,2R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanecarboxylic acid, 2-[[(1R)-1-phenylethyl]amino]-, ethyl ester, (1S,2R)-(163705-86-0)
• EPA Substance Registry System: Cyclohexanecarboxylic acid, 2-[[(1R)-1-phenylethyl]amino]-, ethyl ester, (1S,2R)-(163705-86-0)

Safety Data

• Hazardous Substances Data: 163705-86-0(Hazardous Substances Data)

Upstream product

• 3886-69-9 (R)-1-phenyl-ethyl-amine 
• 121506-74-9 ethyl (-)-N-<(R)-1-phenylethyl>-1-aminocyclohexene-2-carboxylate 
• 1655-07-8 ethyl 2-oxocyclohexane carboxylate 

Downstream Products

• 179601-38-8 (1S,2R)-2-aminocyclohexanecarboxylic acid ethyl ester 
• 163877-12-1 (R,R,R)-2--1-carbethoxycyclohexane 
• 1105703-25-0 (1S,2R)-ethyl 2-(1-phenylethylamino)cyclohexanecarboxylate p-toluenesulfonic acid salt 
• 275815-60-6 (1R,2R)-2-(benzyloxycarbonylamino)cyclohexanecarboxaldehyde 
• 275812-32-3 N-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-N'-((1R,2S)-2-{[3(S)-(4-fluorobenzyl)piperidinyl]methyl}cyclohexyl)urea 
• 213672-84-5 trans-(1R,2R)-1-(benzyloxycarbonylamino)-2-hydroxymethyl-cyclohexane 
• 178112-24-8 [(1R,2R)-2-((R)-1-Phenyl-ethylamino)-cyclohexyl]-methanol 
• 178737-10-5 trans-(1R,2R)-1-amino-2-hydroxymethyl-cyclohexane 
• 1346773-51-0 (1R,2R)-2-((R)-1-Phenyl-ethylamino)-cyclohexanecarboxylic acid ethyl ester; hydrochloride 
• 532977-50-7 (1R,2R)-2-((R)-1-Phenyl-ethylamino)-cyclohexanecarboxylic acid 
• 389057-34-5 trans-(R,R)-2-aminocyclohexane carboxylic acid 
• 5691-19-0 (1R,2R)-2-aminocyclohexanecarboxylic Acid 

Relevant articles and documents

PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present application describes modulators of MIP-1 of formula (I) : or stereoisomers or pharmaceutically acceptable salts thereof, wherein m, Q, T, W, Z, R1, R3, R4, R5, R5a and R5b, are as set forth above. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using the modulators are disclosed.

Asymmetric catalytic hydrogenation process for preparation of chiral cyclic beta-aminoesters

A novel process for the asymmetric synthesis of substituted cyclic β-amino-carboxylates of the type shown in the specification from appropriate β-enamino-ester starting materials is described. These compounds are useful as intermediates for MMP and TACE i

A novel chiral super-Lewis acidic catalyst for enantioselective synthesis

-